Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study

References

• Harris E. Infertility affects 1 in 6 people globally. JAMA. 2023;329(17):1443.
   Web of Science ®Google Scholar
• La marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update. 2014;20(1):124–140. doi:10.1093/humupd/dmt037
   PubMed Web of Science ®Google Scholar
• Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23(2):211–220. doi:10.1093/humupd/dmw047
   PubMed Web of Science ®Google Scholar
• Nargund G, Datta AK, Fauser B. Mild stimulation for in vitro fertilization. Fertil Steril. 2017;108(4):558–567. doi:10.1016/j.fertnstert.2017.08.022
   PubMed Web of Science ®Google Scholar
• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Sterility. 2011;95(3):1031–1036. doi:10.1016/j.fertnstert.2010.10.021
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao Y, Yu Y, et al. Altered amphiregulin expression induced by diverse luteinizing hormone receptor reactivity in granulosa cells affects IVF outcomes. Reprod Biomed Online. 2015;30(6):593–601. doi:10.1016/j.rbmo.2015.03.001
   PubMed Web of Science ®Google Scholar
• Behre HM, Howles CM, Longobardi S. Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation. Reprod Biomed Online. 2015;31(3):339–346. doi:10.1016/j.rbmo.2015.06.002
   PubMed Web of Science ®Google Scholar
• Lehert P, Kolibianakis EM, Venetis CA, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol. 2014;12(1):17. doi:10.1186/1477-7827-12-17
   PubMedGoogle Scholar
• Canosa SCA, Mercaldo N, Mercaldo N, et al. Effect of rLH supplementation during controlled ovarian stimulation for IVF: evidence from a retrospective analysis of 1470 poor/suboptimal/normal responders receiving either rFSH plus rLH or rFSH Alone. J Clin Med. 2022;11(6):1575. doi:10.3390/jcm11061575
   PubMed Web of Science ®Google Scholar
• Bühler K, Fischer R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecological Endocrinol. 2012;28(5):345–350. doi:10.3109/09513590.2011.633128
   PubMed Web of Science ®Google Scholar
• Mennini FS, Marcellusi A, Viti R, et al. Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF. Reprod Biol Endocrinol. 2018;16(1):68. doi:10.1186/s12958-018-0386-2
   PubMedGoogle Scholar
• Tayyar KS, Kahraman S. Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only. Arch Med Sci. 2019;15(3):673–679. doi:10.5114/aoms.2017.72408
   PubMed Web of Science ®Google Scholar
• Polyzos NP, De Vos M, Corona R, et al. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study. Hum Reprod. 2013;28(5):1254–1260. doi:10.1093/humrep/det045
   PubMed Web of Science ®Google Scholar
• Chen MJ, Yi YC, Guu HF, et al. A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol. Front Endocrinol. 2022;13:931756. doi:10.3389/fendo.2022.931756
   PubMed Web of Science ®Google Scholar
• Pandey S, Pandey S, Maheshwari A, Bhattacharya S. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci. 2010;3(2):62–67. doi:10.4103/0974-1208.69332
   PubMedGoogle Scholar
• Hu D, Huang B, Xiong M, et al. Impact of elevated body mass index on cumulative live birth rate and obstetric safety in women undergoing assisted reproductive technology. Sci Rep. 2022;12(1):18858. doi:10.1038/s41598-022-23576-0
   PubMed Web of Science ®Google Scholar
• Ma H, Mao R, Wang R, et al. Effects of inactivated COVID-19 vaccinations on the IVF/ICSI-ET live birth rate and pregnancy complication in a population of southern China: a retrospective cohort study. J Evid Based Med. 2023;16(2):107–110. doi:10.1111/jebm.12528
   PubMedGoogle Scholar
• Balaban B, Brison D, Calderon G. Medicine ASiR, Embryology ESIGo: the Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting†. Hum Reprod. 2011;26(6):1270–1283. doi:10.1093/humrep/der037
   PubMedGoogle Scholar
• Davis OK, Brinsden PR. A textbook of in vitro fertilization and assisted reproduction. new york: the Parthenon publishing group, 1999:1–564. Price: $110.00. Fertil Sterility. 2000;73(6):1270–1271. doi:10.1016/S0015-0282(00)00474-X
   Google Scholar
• De Neubourg DGJ, Mangelschots K, Van Royen E, Vercruyssen M, Elseviers M. Single top quality embryo transfer as a model for prediction of early pregnancy outcome. Hum Reprod. 2004;19(6):1476–1479. doi:10.1093/humrep/deh283
   PubMed Web of Science ®Google Scholar
• Gardner DLM, Stevens J, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer[J]. Fertil Steril. 2000;73(6):1155–1158. doi:10.1016/S0015-0282(00)00518-5
   PubMed Web of Science ®Google Scholar
• Yang C, Dong N, Li F, Ji Y, Pan Y, She H. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles. J ovarian Res. 2022;15(1):74. doi:10.1186/s13048-022-01009-w
   PubMed Web of Science ®Google Scholar
• Aalabaf-Sabaghi M. Decision modelling for health economic evaluation. Br J Soc Med. 2007;61:9.
   Google Scholar
• National bureau of statistics of china: households’ income and consumption expenditure in 2021; 2022. Available from: http://wwwstatsgovcn/english/PressRelease/202201/t20220118_1826649html. Accessed June 4, 2024.
   Google Scholar
• Gameiro S, Finnigan A. Long-term adjustment to unmet parenthood goals following ART: a systematic review and meta-analysis. Human Reproduction Update. 2017;23(3):322–337. doi:10.1093/humupd/dmx001
   PubMed Web of Science ®Google Scholar
• Owen A, Sparzak PB. Age-Related Fertility Decline. In: Paul Sparzak Declares No Relevant Financial Relationships with Ineligible Companies. Treasure Island (FL): StatPearls Publishing; Copyright © 2023, StatPearls Publishing LLC; 2023.
   Google Scholar
• Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–1624. doi:10.1093/humrep/der092
   PubMed Web of Science ®Google Scholar
• Esteves SC, Alviggi C, Humaidan P, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol. 2019;10:814. doi:10.3389/fendo.2019.00814
   PubMed Web of Science ®Google Scholar
• Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens JJ. Coomarasamy A: conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Human Reproduction Update. 2019;25(2):202–223. doi:10.1093/humupd/dmy044
   PubMed Web of Science ®Google Scholar
• Kundu S, Pramanick K, Paul S, Bandyopadhyay A, Mukherjee D. Expression of LH receptor in nonpregnant mouse endometrium: LH induction of 3β-HSD and de novo synthesis of progesterone. J Endocrinol. 2012;215(1):151–165. doi:10.1530/JOE-11-0486
   PubMed Web of Science ®Google Scholar
• Freis A, Germeyer A, Jauckus J, et al. Endometrial expression of receptivity markers subject to ovulation induction agents. Arch Gynecol Obstetrics. 2019;300(6):1741–1750. doi:10.1007/s00404-019-05346-y
   PubMed Web of Science ®Google Scholar
• Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online. 2003;7(1):59–64. doi:10.1016/S1472-6483(10)61729-4
   PubMedGoogle Scholar
• Wang Y, Li L, Deng K, et al. Comparison of the combination of recombinant follicle-stimulating hormone and recombinant luteinizing hormone protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: a systematic review and meta-analysis. J Evid Based Med. 2020;13(3):215–226. doi:10.1111/jebm.12390
   PubMedGoogle Scholar
• Ata B, Liñán A, Kalafat E, et al. Effect of the endometrial thickness on the live birth rate: insights from 959 single euploid frozen embryo transfers without a cutoff for thickness. Fertil Steril. 2023;120(1):91–98. doi:10.1016/j.fertnstert.2023.02.035
   PubMed Web of Science ®Google Scholar
• Gursu T, Goksever Celik H, Eraslan A, et al. Impact of endometrial thickness change in response to progesterone on live birth rates embryo transfers with fresh oocyte donation cycles. J Obstet Gynaecol. 2022;42(7):3260–3267. doi:10.1080/01443615.2022.2112022
   PubMedGoogle Scholar
• Ribeiro VC, Santos-Ribeiro S, De Munck N, et al. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight. Reprod Biomed Online. 2018;36(4):416–426. doi:10.1016/j.rbmo.2017.12.016
   PubMed Web of Science ®Google Scholar
• Simeonov M, Sapir O, Lande Y, et al. The entire range of trigger-day endometrial thickness in fresh IVF cycles is independently correlated with live birth rate. Reprod Biomed Online. 2020;41(2):239–247. doi:10.1016/j.rbmo.2020.04.008
   PubMed Web of Science ®Google Scholar
• Messinis IE, Messini CI, Dafopoulos K. The role of gonadotropins in the follicular phase. Ann. N.Y. Acad. Sci. 2010;1205(1):5–11. doi:10.1111/j.1749-6632.2010.05660.x
   PubMedGoogle Scholar
• Loumaye E, Engrand P, Shoham Z, Hillier SG. Baird DT: clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod. 2003;18(2):314–322. doi:10.1093/humrep/deg066
   PubMed Web of Science ®Google Scholar
• Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online. 2007;15(3):326–337. doi:10.1016/S1472-6483(10)60347-1
   PubMed Web of Science ®Google Scholar
• Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril. 1999;71(3):405–414. doi:10.1016/S0015-0282(98)00482-8
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang Q, Wang Y, Li Y. Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. Reprod Biomed Online. 2014;29(3):291–298. doi:10.1016/j.rbmo.2014.05.011
   PubMed Web of Science ®Google Scholar
• Drakopoulos P, Errázuriz J, Santos-Ribeiro S, et al. Cumulative live birth rates in in-vitro fertilization. Minerva ginecologica. 2019;71(3):207–210. doi:10.23736/S0026-4784.18.04347-2
   PubMed Web of Science ®Google Scholar
• Meldrum DR. Introduction: obesity and reproduction. Fertil Steril. 2017;107(4):831–832. doi:10.1016/j.fertnstert.2017.02.110
   PubMed Web of Science ®Google Scholar
• Li Q, Guo S, Yang C, et al. High-fat diet-induced obesity primes fatty acid β-oxidation impairment and consequent ovarian dysfunction during early pregnancy. Ann Translat Med. 2021;9(10):887.
   PubMed Web of Science ®Google Scholar
• Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107(4):840–847. doi:10.1016/j.fertnstert.2017.01.017
   PubMed Web of Science ®Google Scholar
• Merve D, Emre S, Yucel COS, et al. The effect of recombinant LH addition to recombinant FSH on assisted reproductive technologies outcomes in overweight and obese patients without polycystic ovary syndrome. Open J Obst Gynecol. 2020;10:4.
   Google Scholar
• Vollenhoven B, Hunt S, Bollag L. Ovarian ageing and the impact on female fertility. F1000Research. 2018;7:7. doi:10.12688/f1000research.13350.2
   PubMedGoogle Scholar
• Baird DT, Collins J, Egozcue J, Evers LH, Tarlatzis B. Fertility and ageing. Human Reproduction Update. 2005;11(3):261.
   PubMed Web of Science ®Google Scholar